Literature DB >> 19897557

Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension.

B Sztrymf1, R Souza, L Bertoletti, X Jaïs, O Sitbon, L C Price, G Simonneau, M Humbert.   

Abstract

Acute right ventricular failure in the setting of pulmonary arterial hypertension (PAH) often requires hospitalisation in intensive care units (ICU) to manage the subsequent low cardiac output and its consequences. There are very few data on these acute events. We recorded demographic, clinical and biological data and therapy in consecutive patients suffering from acute right heart failure requiring catecholamine treatment in the ICU of the French referral centre for pulmonary hypertension. These variables were analysed according to the survival status in ICU. 46 patients were included, the mean age was 50.3 yrs. ICU mortality was 41%. We found no difference in terms of demographics, clinical data, last haemodynamic measurements at admission. Systemic arterial pressure was significantly lower in the subgroup of patients whose clinical course was fatal. Plasma brain natriuretic peptide (BNP), C-reactive protein (CRP), serum sodium and creatinine at admission correlated with survival. Demonstration of an infection during the ICU stay was associated with a worse prognosis. These preliminary results underline the importance of some simple clinical and biological parameters in the prognostic evaluation of acute heart failure in the setting of PAH. Whether these parameters can guide therapy needs to be further investigated.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19897557     DOI: 10.1183/09031936.00070209

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  64 in total

Review 1.  Today's and tomorrow's imaging and circulating biomarkers for pulmonary arterial hypertension.

Authors:  Marjorie Barrier; Jolyane Meloche; Maria Helena Jacob; Audrey Courboulin; Steeve Provencher; Sébastien Bonnet
Journal:  Cell Mol Life Sci       Date:  2012-03-25       Impact factor: 9.261

2.  Association Between Initial Oral Therapy and Outcomes in Systemic Sclerosis-Related Pulmonary Arterial Hypertension.

Authors:  Matthew R Lammi; Stephen C Mathai; Lesley Ann Saketkoo; Robyn T Domsic; Christine Bojanowski; Daniel E Furst; Virginia D Steen
Journal:  Arthritis Rheumatol       Date:  2016-03       Impact factor: 10.995

3.  Plasma miR-451 with echocardiography serves as a diagnostic reference for pulmonary hypertension.

Authors:  Xiao-Wei Song; Lu-Lu Zou; Ling Cui; Song-Hua Li; Yong-Wen Qin; Xian-Xian Zhao; Qing Jing
Journal:  Acta Pharmacol Sin       Date:  2018-05-24       Impact factor: 6.150

Review 4.  Management of pulmonary hypertension and right heart failure in the intensive care unit.

Authors:  Jonathan Grinstein; Mardi Gomberg-Maitland
Journal:  Curr Hypertens Rep       Date:  2015-05       Impact factor: 5.369

Review 5.  The right ventricle in pulmonary arterial hypertension: disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure.

Authors:  John J Ryan; Stephen L Archer
Journal:  Circ Res       Date:  2014-06-20       Impact factor: 17.367

Review 6.  Severe pulmonary arterial hypertension: stratification of medical therapies, mechanical support, and lung transplantation.

Authors:  Sonja Darrell Bartolome; Fernando Torres
Journal:  Heart Fail Rev       Date:  2016-05       Impact factor: 4.214

Review 7.  [Treatment of acute and chronic right ventricular failure].

Authors:  T Kramm; S Guth; C B Wiedenroth; H A Ghofrani; E Mayer
Journal:  Med Klin Intensivmed Notfmed       Date:  2016-05-30       Impact factor: 0.840

8.  Intravenous fasudil improves in-hospital mortality of patients with right heart failure in severe pulmonary hypertension.

Authors:  Rong Jiang; Zi-Sheng Ai; Xin Jiang; Ping Yuan; Dong Liu; Qin-Hua Zhao; Jing He; Lan Wang; Mardi Gomberg-Maitland; Zhi-Cheng Jing
Journal:  Hypertens Res       Date:  2015-03-19       Impact factor: 3.872

Review 9.  Novel putative pharmacological therapies to protect the right ventricle in pulmonary hypertension: a review of current literature.

Authors:  Gerald J Maarman; Rainer Schulz; Karen Sliwa; Ralph Theo Schermuly; Sandrine Lecour
Journal:  Br J Pharmacol       Date:  2017-02-24       Impact factor: 8.739

10.  Autophagy mechanism of right ventricular remodeling in murine model of pulmonary artery constriction.

Authors:  Natia Qipshidze; Neetu Tyagi; Naira Metreveli; David Lominadze; Suresh C Tyagi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-11-18       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.